Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Yong-Chen Lu

Concepts (182)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
14
2025
148
4.330
Why?
Receptors, Antigen, T-Cell
11
2025
49
3.240
Why?
Lymphocytes, Tumor-Infiltrating
18
2025
77
3.160
Why?
Immunotherapy
7
2025
231
2.660
Why?
T-Lymphocytes
10
2025
325
2.640
Why?
Immunotherapy, Adoptive
8
2019
161
2.440
Why?
Neoplasms
10
2024
1246
2.390
Why?
CD4-Positive T-Lymphocytes
5
2024
158
1.590
Why?
Cancer Vaccines
4
2021
80
1.380
Why?
High-Throughput Nucleotide Sequencing
3
2021
162
1.220
Why?
Mutation
12
2019
1275
0.930
Why?
Single-Cell Analysis
3
2022
63
0.750
Why?
CD8-Positive T-Lymphocytes
9
2025
127
0.740
Why?
Immune System
1
2020
43
0.670
Why?
Alcohol Oxidoreductases
1
2019
12
0.630
Why?
HLA-DP beta-Chains
2
2017
2
0.600
Why?
Neoplasm Proteins
2
2017
320
0.580
Why?
Urinary Bladder Neoplasms
1
2019
158
0.560
Why?
Genetic Therapy
2
2017
120
0.550
Why?
DNA-Binding Proteins
1
2019
410
0.520
Why?
Melanoma
3
2016
278
0.510
Why?
Proto-Oncogene Proteins p21(ras)
4
2019
67
0.450
Why?
Immunodominant Epitopes
2
2015
8
0.450
Why?
Humans
31
2025
50417
0.430
Why?
Animals
12
2024
13062
0.420
Why?
Cytokines
4
2019
602
0.420
Why?
Protein Phosphatase 1
1
2013
6
0.420
Why?
Phosphoprotein Phosphatases
1
2013
17
0.420
Why?
Lymphocyte Activation
5
2021
169
0.410
Why?
Proto-Oncogene Proteins c-rel
2
2010
5
0.410
Why?
Antibodies, Monoclonal
1
2016
459
0.390
Why?
Colorectal Neoplasms
3
2019
256
0.360
Why?
Neoplasm Metastasis
3
2022
230
0.350
Why?
CCAAT-Enhancer-Binding Protein-beta
1
2009
4
0.320
Why?
Toll-Like Receptors
1
2009
26
0.320
Why?
Transcriptome
2
2022
314
0.310
Why?
CCAAT-Enhancer-Binding Protein-delta
1
2009
22
0.310
Why?
Lipopolysaccharides
2
2022
196
0.310
Why?
Glioblastoma
2
2021
94
0.300
Why?
Signal Transduction
5
2019
1608
0.280
Why?
Toll-Like Receptor 4
1
2008
52
0.280
Why?
Adoptive Transfer
3
2018
29
0.250
Why?
Cells, Cultured
5
2021
1564
0.250
Why?
Gene Expression Profiling
2
2021
1020
0.240
Why?
Autoantigens
2
2015
49
0.230
Why?
T-Lymphocytes, Regulatory
2
2016
81
0.220
Why?
Gene Library
2
2014
39
0.220
Why?
Carcinoma, Hepatocellular
1
2025
191
0.200
Why?
Nephritis
1
2022
23
0.190
Why?
Clone Cells
2
2019
72
0.190
Why?
Receptors, Immunologic
1
2022
35
0.190
Why?
Middle Aged
9
2025
12579
0.190
Why?
Ureteral Obstruction
1
2022
57
0.190
Why?
Liver Neoplasms
1
2025
321
0.180
Why?
HLA-A Antigens
2
2019
10
0.180
Why?
Human papillomavirus 16
1
2021
43
0.180
Why?
Adaptor Proteins, Signal Transducing
2
2014
200
0.180
Why?
Tumor Suppressor Protein p53
2
2022
212
0.180
Why?
T-Cell Antigen Receptor Specificity
2
2017
4
0.180
Why?
Membrane Glycoproteins
1
2022
246
0.180
Why?
Papillomavirus Vaccines
1
2021
66
0.170
Why?
Interleukin-2
2
2017
70
0.160
Why?
Renal Insufficiency, Chronic
1
2022
173
0.160
Why?
Smad5 Protein
1
2019
1
0.160
Why?
Mucin-4
1
2019
1
0.160
Why?
Uterine Cervical Neoplasms
1
2021
275
0.150
Why?
Cell Differentiation
1
2021
640
0.150
Why?
Male
7
2025
25867
0.140
Why?
Epitopes, T-Lymphocyte
2
2014
26
0.140
Why?
Administration, Intravenous
1
2017
70
0.140
Why?
Hematopoietic Stem Cell Transplantation
1
2022
580
0.140
Why?
Colonic Neoplasms
1
2019
155
0.140
Why?
Aged
3
2025
9738
0.140
Why?
Membrane Proteins
1
2019
337
0.140
Why?
Flow Cytometry
3
2016
472
0.130
Why?
Exome
2
2014
48
0.130
Why?
Cell Line, Tumor
2
2017
1392
0.130
Why?
Gene Expression Regulation
2
2019
948
0.130
Why?
CTLA-4 Antigen
1
2016
22
0.130
Why?
T-Lymphocytes, Helper-Inducer
1
2016
39
0.130
Why?
Programmed Cell Death 1 Receptor
1
2016
35
0.130
Why?
Transcription Factors
1
2019
561
0.120
Why?
Protein Binding
2
2014
648
0.120
Why?
Female
11
2025
27053
0.120
Why?
Transplantation, Autologous
1
2017
480
0.120
Why?
Adult
7
2021
13561
0.120
Why?
Gastrointestinal Neoplasms
1
2015
40
0.120
Why?
Treatment Outcome
4
2021
5265
0.120
Why?
Neutrophils
2
2014
142
0.120
Why?
Time Factors
2
2021
2933
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2019
831
0.120
Why?
Respiratory Burst
1
2014
4
0.110
Why?
Hepatitis B e Antigens
1
2014
4
0.110
Why?
Histocompatibility Antigens
1
2014
5
0.110
Why?
Chemotaxis, Leukocyte
1
2014
13
0.110
Why?
Epitope Mapping
1
2014
6
0.110
Why?
Bile Ducts, Intrahepatic
1
2014
11
0.110
Why?
Bile Duct Neoplasms
1
2014
25
0.110
Why?
Cholangiocarcinoma
1
2014
23
0.110
Why?
Th1 Cells
1
2014
52
0.110
Why?
Monocytes
1
2014
130
0.110
Why?
Alleles
1
2014
252
0.110
Why?
Peptides
1
2014
218
0.100
Why?
Amino Acid Sequence
1
2014
575
0.100
Why?
Gene Knockdown Techniques
1
2013
104
0.100
Why?
NF-kappa B
2
2011
306
0.100
Why?
Genes, T-Cell Receptor
2
2022
5
0.100
Why?
Base Sequence
1
2013
622
0.100
Why?
TNF Receptor-Associated Factor 2
1
2011
3
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
568
0.090
Why?
Molecular Sequence Data
1
2013
760
0.090
Why?
Autoimmunity
1
2011
34
0.090
Why?
Cell Line
1
2014
997
0.090
Why?
Forkhead Transcription Factors
1
2012
110
0.090
Why?
Disease Progression
1
2014
825
0.090
Why?
Lung Neoplasms
1
2016
597
0.090
Why?
Clinical Trials as Topic
1
2013
488
0.090
Why?
Mice
4
2022
5658
0.080
Why?
Clonal Anergy
1
2010
13
0.080
Why?
Protein Kinase C
1
2010
71
0.080
Why?
Dendritic Cells
2
2022
135
0.080
Why?
Remission Induction
2
2021
208
0.080
Why?
Isoenzymes
1
2010
165
0.080
Why?
Interleukin-1 Receptor-Associated Kinases
1
2009
11
0.080
Why?
Myeloid Differentiation Factor 88
1
2009
32
0.080
Why?
Antineoplastic Agents
1
2017
1165
0.080
Why?
Breast Neoplasms
1
2018
1198
0.080
Why?
Transcriptional Activation
1
2009
120
0.080
Why?
Inflammation Mediators
1
2009
110
0.080
Why?
Antigen Presentation
2
2019
25
0.070
Why?
Cell Separation
2
2019
92
0.070
Why?
Complement C3a
1
2007
3
0.070
Why?
Complement C5a
1
2007
3
0.070
Why?
Macrophages
1
2009
365
0.060
Why?
Lymphocyte Count
2
2016
19
0.060
Why?
Tumor Microenvironment
1
2025
221
0.050
Why?
Th17 Cells
1
2022
24
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Neoplasm Grading
1
2021
122
0.050
Why?
Gene Regulatory Networks
1
2022
106
0.040
Why?
Arginine
1
2022
185
0.040
Why?
Nitric Oxide
1
2022
253
0.040
Why?
Host-Pathogen Interactions
1
2021
134
0.040
Why?
Blotting, Western
2
2011
575
0.040
Why?
Transduction, Genetic
1
2019
45
0.040
Why?
Immunologic Memory
1
2019
29
0.040
Why?
Lung
2
2016
493
0.040
Why?
Coculture Techniques
1
2019
140
0.040
Why?
Transplantation Conditioning
1
2019
88
0.040
Why?
Phenotype
2
2012
736
0.040
Why?
Neoplastic Cells, Circulating
1
2019
74
0.040
Why?
Lymphatic Metastasis
1
2019
221
0.040
Why?
Molecular Targeted Therapy
1
2019
122
0.040
Why?
Cell Proliferation
1
2021
980
0.040
Why?
Proteasome Endopeptidase Complex
1
2018
116
0.030
Why?
HLA-DRB1 Chains
1
2017
4
0.030
Why?
Antigen-Presenting Cells
1
2017
22
0.030
Why?
Pilot Projects
1
2019
694
0.030
Why?
Cross Reactions
1
2016
40
0.030
Why?
HLA-C Antigens
1
2015
5
0.030
Why?
ras Proteins
1
2015
65
0.030
Why?
Inflammation
2
2011
607
0.030
Why?
Proto-Oncogene Proteins
1
2015
150
0.030
Why?
Clinical Trials, Phase II as Topic
1
2014
46
0.030
Why?
Chemokines
1
2014
75
0.030
Why?
Vaccination
1
2016
275
0.030
Why?
Receptor, erbB-2
1
2014
73
0.030
Why?
B-Lymphocytes
1
2014
171
0.030
Why?
Recombinant Proteins
1
2014
477
0.030
Why?
Dose-Response Relationship, Immunologic
1
2012
13
0.020
Why?
Whole-Body Irradiation
1
2012
131
0.020
Why?
Polymerase Chain Reaction
1
2011
447
0.020
Why?
Mice, Knockout
1
2011
840
0.020
Why?
Apoptosis
1
2014
1092
0.020
Why?
Mice, Transgenic
1
2010
538
0.020
Why?
Receptor, Anaphylatoxin C5a
1
2007
3
0.020
Why?
Receptors, Chemokine
1
2007
13
0.020
Why?
Complement Activation
1
2007
23
0.020
Why?
Cattle
1
2007
196
0.020
Why?
Actins
1
2007
112
0.020
Why?
Hematopoietic Stem Cells
1
2007
197
0.010
Why?
Fibroblasts
1
2007
338
0.010
Why?
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description